The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol

por Poirier, Steve, Mayer, Gaétan
Publicado 2013

Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain

por Poirier, Steve, Hamouda, Hocine Ait, Villeneuve, Louis, Demers, Annie, Mayer, Gaétan
Publicado 2016

The Anti-Hypercholesterolemic Effect of Low p53 Expression Protects Vascular Endothelial Function in Mice

por Leblond, Francois, Poirier, Steve, Yu, Carol, Duquette, Natacha, Mayer, Gaetan, Thorin, Eric
Publicado 2014

Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation

por Seidah, Nabil G., Poirier, Steve, Denis, Maxime, Parker, Rex, Miao, Bowman, Mapelli, Claudio, Prat, Annik, Wassef, Hanny, Davignon, Jean, Hajjar, Katherine A., Mayer, Gaétan
Publicado 2012